Back to today’s briefing

Story perspectives

UK Approves Groundbreaking Stem Cell Trial for Hearing Loss

7/14/2025

29 2

Summary

Story summary

The UK’s Medicines and Healthcare products Regulatory Agency has greenlit the groundbreaking human trial of Rincell-1, a stem cell therapy designed to combat sensorineural hearing loss. Spearheaded by the University of Sheffield, this pivotal trial will engage 20 patients, exploring the therapy's potential impact in conjunction with cochlear implants.

1 of 1

Story summary

The UK’s Medicines and Healthcare products Regulatory Agency has greenlit the groundbreaking human trial of Rincell-1, a stem cell therapy designed to combat sensorineural hearing loss. Spearheaded by the University of Sheffield, this pivotal trial will engage 20 patients, exploring the therapy's potential impact in conjunction with cochlear implants.